Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Ramirez, M.J. (María Javier) | - |
dc.contributor.advisor | Gil-Bea, F.J. (Francisco J.) | - |
dc.creator | Gereñu-Lopetegi, G. (Gorka) | - |
dc.date.accessioned | 2016-05-11T11:20:34Z | - |
dc.date.available | 2016-05-11T11:20:34Z | - |
dc.date.issued | 2013-04 | - |
dc.date.submitted | 2013-06-13 | - |
dc.identifier.citation | GUEREÑU LOPETEGI, Gorka. “Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF”. Gil Bea, Francisco Javier y Ramírez, María Javier (dir.). Tesis doctoral. Universidad de Navarra, Pamplona, 2013 | es_ES |
dc.identifier.uri | https://hdl.handle.net/10171/40604 | - |
dc.description.abstract | Education and cognitive occupations is commonly associated to reduced risk of Alzheimer¿s disease (AD) dementia. Animal studies have demonstrated that cognitive stimulation (CS) achieved by social/physical activities and/or enriched environments compensates for memory decline. We have elaborated a novel paradigm of CS that is devoid of physical/social activity and enriched environments. 4 months-old Tg2576 mice were cognitively trained for 8 weeks and, after a break of 8 months, long-lasting effects of CS on cognitive abilities and AD-like pathology were measured. MWM and NOR tests showed that deficits in spatial and recognition memories were compensated by CS. These outcomes were accompanied by increased levels of hippocampal post-synaptic markers (PSD95 and NR1) and proteins involved in synaptic formation (Arc, â-catenin). CS softened amyloid pathology in terms of reduced levels of Aâ1-42 and the dodecameric assembly, referred as Aâ*56. CS appeared to affect the APP processing since differences in levels of ADAM17, BACE1 and C99/C83 ratio were found. Tau hyper-phosphorylation and high activities of Tau kinases were also reduced by CS. In contrast, CS did not induce any of these molecular changes in wild-type mice. The present findings suggest beneficial and long-lasting effects of CS early in life on cognitive decline and AD-like pathology. In this research work we have also characterized the role of BDNF on a new mechanism by which cognitive stimulation exerts its beneficial effects on cognitive decline and AD-like pathology. | es_ES |
dc.language.iso | spa | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | * |
dc.subject | Materias Investigacion::Ciencias de la Salud | es_ES |
dc.subject | Neurobiología molecular | es_ES |
dc.title | Efectos de la Estimulación Cognitiva en la Enfermedad de Alzheimer: Implicación de BDNF | es_ES |
dc.type | info:eu-repo/semantics/doctoralThesis | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.